These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 37438981)
1. Plurihormonal Pituitary Neuroendocrine Tumours - A Single Centre Experience. Mihajlović M; Pekić S; Doknić M; Stojanović M; Rašić D; Miljić D; Petakov M; Manojlović Gačić E Int J Surg Pathol; 2024 May; 32(3):470-477. PubMed ID: 37438981 [No Abstract] [Full Text] [Related]
2. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1. Asa SL; Mete O; Riddle ND; Perry A Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858 [TBL] [Abstract][Full Text] [Related]
3. Overview of the 2022 WHO Classification of Pituitary Tumors. Asa SL; Mete O; Perry A; Osamura RY Endocr Pathol; 2022 Mar; 33(1):6-26. PubMed ID: 35291028 [TBL] [Abstract][Full Text] [Related]
4. Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features. Dottermusch M; Ryba A; Ricklefs FL; Flitsch J; Schmid S; Glatzel M; Saeger W; Neumann JE; Schüller U Acta Neuropathol; 2024 Jan; 147(1):16. PubMed ID: 38228887 [TBL] [Abstract][Full Text] [Related]
5. [New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version]. Xie J; Wu ZB Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3723-3726. PubMed ID: 36517420 [TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor expression and clinical outcome of multilineage pituitary tumours expressing PIT1 and SF1. Fookeerah P; Varikatt W; Shingde M; Dexter MAJ; McLean M Endocr Connect; 2023 Nov; 12(11):. PubMed ID: 37851558 [TBL] [Abstract][Full Text] [Related]
9. [Plurihormonal PIT1-lineage pituitary neuroendocrine tumors: a clinicopathological study]. Duan ZJ; Feng J; Zhao HQ; Wang HD; Gui QP; Zhang XF; Ma Z; Hu ZJ; Xiang L; Qi XL Zhonghua Bing Li Xue Za Zhi; 2023 Oct; 52(10):1017-1024. PubMed ID: 37805393 [No Abstract] [Full Text] [Related]
10. Clinicopathologic Correlates of PIT1 and SF1-Multilineage Pituitary Neuroendocrine Tumors and the Diagnostic Utility of NKX2.2 Immunohistochemistry in Pituitary Pathology. Doğukan FM; Karatay H; Yüzkan S; Burhan Ş; Erkan B; Yılmaz-Özgüven B Arch Pathol Lab Med; 2025 Jan; 149(1):83-89. PubMed ID: 38649148 [TBL] [Abstract][Full Text] [Related]
11. Unveiling the identities of null cell tumours: Epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour/adenoma classification. Dottermusch M; Schüller U; Hagel C; Saeger W Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12870. PubMed ID: 36527335 [TBL] [Abstract][Full Text] [Related]
12. Proposal of a clinically relevant working classification of pituitary neuroendocrine tumors based on pituitary transcription factors. Silva-Ortega S; García-Martinez A; Niveiro de Jaime M; Torregrosa ME; Abarca J; Monjas I; Picó Alfonso A; Aranda López I Hum Pathol; 2021 Apr; 110():20-30. PubMed ID: 33321163 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical and ultrastructural review of six cases previously diagnosed as null cell PitNETs. Inoshita N; Yoshimoto T; Takazawa Y; Fukuhara N; Okada M; Nishioka H; Yamada S Brain Tumor Pathol; 2023 Jul; 40(3):158-162. PubMed ID: 37072666 [TBL] [Abstract][Full Text] [Related]
14. Cytokeratin 8/18-negative somatotroph pituitary neuroendocrine tumours (PitNETs, adenomas) show variable morphological features and do not represent a clinicopathologically distinct entity. Soukup J; Cesak T; Hornychova H; Manethova M; Michnova L; Netuka D; Vitovcova B; Cap J; Ryska A; Gabalec F Histopathology; 2021 Sep; 79(3):406-415. PubMed ID: 33738859 [TBL] [Abstract][Full Text] [Related]
16. Primary Pituitary Carcinoids Do Not Exist: A Reappraisal in the Era of Pituitary Neuroendocrine Tumours. Armeni E; Alexandraki KI; Roncaroli F; Grossman AB Arch Med Res; 2023 Dec; 54(8):102841. PubMed ID: 37394342 [TBL] [Abstract][Full Text] [Related]
17. Plurihormonal pituitary adenomas: immunostaining of all pituitary hormones is mandatory for correct classification. Ho DM; Hsu CY; Ting LT; Chiang H Histopathology; 2001 Sep; 39(3):310-9. PubMed ID: 11532042 [TBL] [Abstract][Full Text] [Related]
18. Distribution of E- and N-cadherin in subgroups of non-functioning pituitary neuroendocrine tumours. Øystese KAB; Casar-Borota O; Berg-Johnsen J; Berg JP; Bollerslev J Endocrine; 2022 Jun; 77(1):151-159. PubMed ID: 35674926 [TBL] [Abstract][Full Text] [Related]